Alzheimer’s Disease/Dementia News

The treatment of high BP may slow down the advancement of cognitive decline, according to research presented at the American Heart Association’s Hypertension Scientific Sessions.

A history of migraine was a significant risk factor for Alzheimer's disease and for all-cause dementia, but not vascular dementia, according to a statistical analysis published in the International Journal of Geriatric Psychiatry.

PARIS — Aspirin did not benefit older patients for the primary prevention of CVD, according to a new analysis from the ASPREE trial presented at the European Society of Cardiology Congress.

Moderate exercise may help delay the development of Alzheimer's disease biomarkers in at-risk older adults, according to three studies presented at the 2019 American Psychological Association convention.

Patients with hypertension whose target systolic BP was less than 120 mm Hg had a greater decrease in total brain volume and a smaller increase in cerebral white matter lesion volume compared with those whose target was less than 140 mm Hg, according to results from the SPRINT MIND trial published in JAMA.

Patients who had sustained hypertension in midlife to late life and those with midlife hypertension and late-life hypotension had an increased risk for dementia later in life compared with patients with normal BP in midlife and late life, according to a study published in JAMA.

Study findings published in PLOS Medicine showed that more frequent social contact with friends at age 60 years was linked to lower risk of developing dementia over a 28-year follow-up and higher subsequent cognitive performance over a 15-year follow-up.

Patients aged 50 years who adhered to recommendations from the American Heart Association’s Life’s Simple 7 metric for CV health had a lower risk for dementia later in life, according to a study published in The BMJ.

Altered liver function markers appeared associated with Alzheimer’s disease diagnosis and impaired memory and executive function, as well as amyloid-, tau and neurodegenerative biomarkers of Alzheimer’s pathophysiology, according to study results published in JAMA Network Open.

In the general population, both high and low levels of hemoglobin were linked to a greater long-term risk for dementia, including Alzheimer’s disease, data published in Neurology showed.